Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange |
| |
| Authors: | Matthew R. Sullivan Alexey V. Danilov Frederick Lansigan Nancy M. Dunbar |
| |
| Affiliation: | 1. Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire;2. Department of Hematology/Oncology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire;3. Department of Pathology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire |
| |
| Abstract: | Drug associated thrombotic microangiopathy (TMA) is a rare event causing thrombocytopenia, microangiopathic anemia, renal failure, and neurologic abnormalities. Here, we present a case of TMA that occurred during the first cycle of treatment with carfilzomib for relapsed multiple myeloma. J. Clin. Apheresis, 2014. © 2014 Wiley Periodicals, Inc. |
| |
| Keywords: | plasma exchange carfilzomib thrombotic microangiopathy multiple myeloma |
|
|
